Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Toxicol Appl Pharmacol. 2006 Jun 27;216(1):69–79. doi: 10.1016/j.taap.2006.04.011

Fig. 3.

Fig. 3

Evaluation via confocal microscopy of UROtsa cells before, during, and after transformation with MMAIII. Morphology of untreated UROtsa cells (A). Morphology of URO-MSC cells treated with 0.05 μM MMAIII for 12 (B), 24 (C), and 52 (D) weeks. Magnification used for photographs is ×200.